Early Monitoring of Ribavirin Plasma Concentrations May Predict Anemia and Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients-Reference-Cited by-同舟云学术

Early Monitoring of Ribavirin Plasma Concentrations May Predict Anemia and Early Virologic Response in HIV/Hepatitis C Virus-Coinfected Patients

Published:2005-08-01 Issue:4 Volume:39 Page:401-405
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Rendón Ana Lucía,Núñez Marina,Romero Miriam,Barreiro Pablo,Martín-Carbonero Luz,García-Samaniego Javier,Jiménez-Nácher Inmaculada,González-Lahoz Juan,Soriano Vincent

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference30 articles.

1. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial.;Manns;Lancet,2001

2. Factors contributing to ribavirin-induced anemia.;Nomura;J Gastroenterol Hepatol,2004

3. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.;Fried;N Engl J Med,2002

4. A dynamic model to predict sustained virological response to combination peginterferon alfa-2a (40KD) (PEGASYS) and ribavirin (COPEGUS) therapy in patients with chronic hepatitis C [abstract 995].;Ferenci;Hepatology,2003

5. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.;Soriano;Antivir Ther,2004

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#;Intensive Care Medicine;2020-05-07

2. Peg-interferon and ribavirin treatment in HIV/HCV co-infected patients in Thailand: efficacy, safety and pharmacokinetics;Tropical Medicine & International Health;2018-01-10

3. Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals;World Journal of Hepatology;2017-12-08

4. Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C;Antiviral therapy;2017

5. Lower Ribavirin Plasma Concentrations in HCV/HIV–Coinfected Patients Than in HCV-Monoinfected Patients Despite Similar Dosage;Therapeutic Drug Monitoring;2015-12